An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

NCT06782789 · clinicaltrials.gov ↗
RECRUITING
Status
96
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna